Donaldson Capital Management’s Idexx Laboratories IDXX Stock Holding History

Donaldson Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,299	Closed	-$1.8M	–	236
2022 Q1	$1.8M	Buy	3,299 +2,081	+171%	+$1.09M	0.08%	92
2021 Q4	$802K	Sell	1,218 -107	-8%	-$67.2K	0.04%	142
2021 Q3	$824K	Sell	1,325 -11	-0.8%	-$7.39K	0.04%	127
2021 Q2	$844K	Sell	1,336 -129	-9%	-$71.2K	0.04%	125
2021 Q1	$717K	Sell	1,465 -25	-2%	-$12.5K	0.04%	128
2020 Q4	$745K	Sell	1,490 -84	-5%	-$37.6K	0.04%	118
2020 Q3	$619K	Sell	1,574 -257	-14%	-$95K	0.04%	122
2020 Q2	$604K	Buy	1,831 +121	+7%	+$35K	0.04%	118
2020 Q1	$414K	Buy	1,710 +392	+30%	+$102K	0.04%	131
2019 Q4	$344K	Buy	1,318 +279	+27%	+$73.5K	0.02%	172
2019 Q3	$283K	Buy	+1,039	New	+$289K	0.02%	172
2018 Q4	–	Sell	-1,233	Closed	-$308K	–	182
2018 Q3	$308K	Buy	+1,233	New	+$299K	0.03%	147

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Donaldson Capital Management's IDXX Position: Q2 2022 in Review

Donaldson Capital Management sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 3,299 shares — an estimated $1.8M sold.

Donaldson Capital Management first reported a position in IDXX in Q3 2018 and held it in 12 quarters. The position peaked at $1.8M in Q1 2022. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

Donaldson Capital Management reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
Donaldson Capital Management sold 3,299 Idexx Laboratories shares in Q2 2022, an estimated $1.8M.
Donaldson Capital Management first reported a position in Idexx Laboratories in Q3 2018 and held it in 12 quarters.
Donaldson Capital Management's Idexx Laboratories position peaked at $1.8M in Q1 2022.
956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on Donaldson Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.